47 天前 - … to be at a higher risk of severe COVID-19 outcomes. The … molnupiravir treatment,
suggesting a favourable safety … and safety of molnupiravir for treating mild-to-moderate COVID-…

53 天前 - … patients with coronavirus disease 2019 (COVID-19) with normal or mild renal
impairment (… We performed a retrospective territory-wide observational study evaluating the safety …

69 天前 - … and safety of molnupiravir against COVID-19. Based on our discussion mentioned
above, molnupiravir, it appears to be effective for mild to moderate cases as well as safe at …

98 天前 - … safety of molnupiravir and favipiravir in outpatients with mild to moderate COVID-19
and at risk of severe COVID… a substantial benefit of molnupiravir over no treatment but rather …

112 天前 - … safety and effectiveness of Nirmatrelvir/Ritonavir versus Molnupiravir in the treatment
of mild-to-moderate COVID-… in cancer patients with COVID-19, Molnupiravir could be safer …

137 天前 - … safety of azvudine, nirmatrelvir/ritonavir, and molnupiravir in adult patients with
mild-to-moderate COVID… patients with mild-to-moderate COVID-19 (asymptomatic, mild, and …

159 天前 - … safety of small-molecule antivirals for treating coronavirus … /ritonavir over molnupiravir
in reducing hospitalization risk … adult patients with mild or moderate COVID-19 compared …

160 天前 - … 1,074,856 outpatients with COVID-19 in Hong Kong showed that molnupiravir use
was … A retrospective cohort study of 920 patients with mild-to-moderate COVID-19 who were …

176 天前 - … CONCLUSIONS: MOV caused a reduction in the risk of hospitalization or death
in mild COVID-19 patients, and molnupiravir was also found to be well tolerated and safe …

200 天前 - … mild COVID-19. The aim of this systematic review was to find out the safety and efficacy
of Molnupiravir … using the keywords such as “Molnupiravir”, “COVID19”, “Oral antiviral pill…